HomeNewsBusinessReal EstateAround 40% commercial space occupiers intend to lease new office space in next six to eight months: Report

Around 40% commercial space occupiers intend to lease new office space in next six to eight months: Report

De-densification, expansion plans may lead to signs of recovery for the office sector by 2021, according to Colliers Research.

July 01, 2020 / 15:25 IST
Story continues below Advertisement

As many as 40 percent commercial space occupiers intend to lease new office space in the next six to eight months while 5 percent want to take up a flexible workspace and 12 percent plan to incorporate a flex and core model to tackle the challenges brought by the coronavirus pandemic, according to a new report.

Most commercial space occupiers are currently focusing on building a ‘flex and core’ portfolio that includes a flexible office space for medium and long-term lease for core operations and de-densification of office spaces. This coupled with expansion plans will augur well for the leasing activity leading signs of recovery by 2021, Colliers Research has said.

Story continues below Advertisement

The survey said that most occupiers are evaluating lowering workplace density by up to 20 percent compared to pre-COVID situation. As many as 25 percent occupiers stated that they plan to expand their footprint over the next six to eight months and almost half intend to expand their CRE portfolio by up to 20 percent, reflecting positive occupier sentiment in the market.

Among occupiers planning to expand their CRE portfolio in the next 6-8 months, 40 percent intend to lease new office space, another 5 percent intend to lease flexible workspace while 12 percent plan to incorporate a flex and core model, the report noted.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show